Related Experiment Video
Updated: Jul 18, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Identifying and Treating Vulnerable Atherosclerotic Plaques
John A Ambrose1, Avinash V Sharma1
1Division of Cardiology, Department of Medicine, UCSF Fresno Medical Education Program, Fresno, California.
Insights
Identifying vulnerable plaques causing acute coronary syndromes is key. New imaging techniques help detect these nonobstructive, high-risk plaques for preventive strategies against myocardial infarction.
Area of Science:
- Cardiology
- Vascular Biology
- Medical Imaging
Background:
- Acute coronary syndromes often result from coronary thrombosis on disrupted or eroded atherosclerotic plaques.
- These vulnerable plaques, typically nonobstructive, are the primary cause of myocardial infarction and sudden cardiac death.
- Traditional cardiology focused on obstructive lesions, overlooking vulnerable plaques.
Purpose of the Study:
- To explore the identification and management of vulnerable, thrombus-prone plaques.
- To discuss novel preventive strategies targeting asymptomatic high-risk plaques.
- To review noninvasive and interventional approaches for managing these lesions.
Main Methods:
- Utilizing computed tomographic angiography (CTA) to identify vulnerable plaques.
- Employing intravascular imaging during invasive coronary angiography for plaque detection.
- Analyzing noninvasive techniques and systemic therapies for patient management.
Main Results:
- CTA and intravascular imaging can identify a majority of vulnerable plaques before symptom onset.
- These imaging modalities enable the detection of nonobstructive, yet high-risk, plaques.
- New preventive strategies can be developed based on early plaque identification.
Conclusions:
- Vulnerable plaque identification is crucial for preventing thrombotic events like myocardial infarction.
- Noninvasive and systemic therapies offer avenues for managing patients with these lesions.
- A novel interventional paradigm may emerge for treating thrombus-prone plaques.
Abstract:
Acute coronary syndromes and, in particular, ST-elevation myocardial infarction are usually caused by coronary thrombosis in which the thrombus develops either on a disrupted plaque (usually a thin-capped fibroatheroma) or an eroded atherosclerotic plaque. These thrombus-prone plaques are vulnerable or high-risk. Although, traditionally, cardiologists have concentrated on treating significant coronary obstruction, there has been great interest over the last 2 decades in possibly preventing the thrombotic causes of myocardial infarction/sudden coronary death by mostly identifying and stabilizing these asymptomatic vulnerable or high-risk plaques, which, at least on invasive angiography, are mostly nonobstructive. Computed tomographic angiography and intravascular imaging during invasive coronary angiography have now been shown to identify a majority of these vulnerable or high-risk plaques before symptoms, thus opening up new preventive strategies. In conclusion, this article discusses the identification and management of these thrombus-prone lesions and patients with these lesions either with noninvasive techniques and systemic therapies or possibly through a new and bold interventional paradigm.
More Related Videos
Related Concept Videos
Atherosclerosis III: Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management
Atherosclerosis I: Introduction
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures

